Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe record history shows a new revision v3.5.0 added and revision v3.4.3 removed.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, reflecting the latest site release.SummaryDifference0.1%

- Check73 days agoChange DetectedOnly the site revision line changed: the history shows removal of Revision: v3.4.0 and addition of Revision: v3.4.1, indicating a background update rather than modifications to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedNew UI shows color-coded diffs (green for additions, red for deletions) and adds a glossary toggle, plus minor wording and revision-label changes (e.g., No FEAR Act data capitalization, Revision: v3.4.0) that do not affect study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.